We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Gears Up to Post Q4 Earnings: What's in the Offing?
Read MoreHide Full Article
Key Takeaways
IEX reports Q4 results on Feb. 4, with consensus revenues of $881.6M and adjusted EPS of $2.04.
IDEX's HST and FMT units are expected to grow on pharma demand, water projects and higher volumes.
IEX's FSDP segment is seen declining, while recent optics and material science deals may aid performance.
IDEX Corporation (IEX - Free Report) is scheduled to release fourth-quarter 2025 results on Feb. 4, before market open.
The Zacks Consensus Estimate for fourth-quarter earnings has remained steady in the past 30 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 4%.
The consensus estimate for revenues is pegged at $881.6 million, indicating an increase of 2.2% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.04 per share, remaining steady from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strong momentum in the pharma, life science, semiconductor consumables and data center businesses. Also, the targeted growth initiatives in the space business and strength in defense markets are expected to have aided the segment’s performance in the fourth quarter. We expect the HST segment’s revenues to be $396.2 million, indicating an increase of 6.2% year over year.
An increase in demand for products across the municipal water business is expected to have benefited the Fluid & Metering Technologies (FMT) segment. Higher volume in the industrial businesses is likely to have been a tailwind as well. We expect the segment’s revenues to be $306.9 million, up 2.6% year over year.
In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technologies offerings. The acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets. In December 2023, IEX acquired advanced material science solutions provider STC Material Solutions, which expanded its expertise in material sciences. These acquisitions are likely to have augmented the company’s performance.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from unfavorable timing of dispensing projects in emerging markets and slower equipment replenishment. Also, weakness in the fire OEM business and decrease in demand for rescue tools have also been acting as a headwind for the segment’s performance. Our estimate for the segment’s revenues stands at $187.1 million, indicating a 3% decline year over year.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $2.04 per share. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank #4 (Sell).
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Xylem Inc. (XYL - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank of 3 at present. The company is slated to release fourth-quarter 2025 results on Feb. 10.
Xylem’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.7%.
Kennametal Inc. (KMT - Free Report) has an Earnings ESP of +8.57% and a Zacks Rank of 1 at present. The company is scheduled to release second-quarter fiscal 2026 results on Feb. 4.
KMT’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 26.9%.
Watts Water Technologies, Inc. (WTS - Free Report) has an Earnings ESP of +0.59% and a Zacks Rank of 2 at present. The company is slated to release fourth-quarter 2025 results on Feb. 11.
Watts Water’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 10.9%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IDEX Gears Up to Post Q4 Earnings: What's in the Offing?
Key Takeaways
IDEX Corporation (IEX - Free Report) is scheduled to release fourth-quarter 2025 results on Feb. 4, before market open.
The Zacks Consensus Estimate for fourth-quarter earnings has remained steady in the past 30 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 4%.
The consensus estimate for revenues is pegged at $881.6 million, indicating an increase of 2.2% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.04 per share, remaining steady from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strong momentum in the pharma, life science, semiconductor consumables and data center businesses. Also, the targeted growth initiatives in the space business and strength in defense markets are expected to have aided the segment’s performance in the fourth quarter. We expect the HST segment’s revenues to be $396.2 million, indicating an increase of 6.2% year over year.
An increase in demand for products across the municipal water business is expected to have benefited the Fluid & Metering Technologies (FMT) segment. Higher volume in the industrial businesses is likely to have been a tailwind as well. We expect the segment’s revenues to be $306.9 million, up 2.6% year over year.
In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technologies offerings. The acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets. In December 2023, IEX acquired advanced material science solutions provider STC Material Solutions, which expanded its expertise in material sciences. These acquisitions are likely to have augmented the company’s performance.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from unfavorable timing of dispensing projects in emerging markets and slower equipment replenishment. Also, weakness in the fire OEM business and decrease in demand for rescue tools have also been acting as a headwind for the segment’s performance. Our estimate for the segment’s revenues stands at $187.1 million, indicating a 3% decline year over year.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
IDEX Corporation Price and EPS Surprise
IDEX Corporation price-eps-surprise | IDEX Corporation Quote
Earnings Whisper
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $2.04 per share. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Xylem Inc. (XYL - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank of 3 at present. The company is slated to release fourth-quarter 2025 results on Feb. 10.
Xylem’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.7%.
Kennametal Inc. (KMT - Free Report) has an Earnings ESP of +8.57% and a Zacks Rank of 1 at present. The company is scheduled to release second-quarter fiscal 2026 results on Feb. 4.
KMT’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 26.9%.
Watts Water Technologies, Inc. (WTS - Free Report) has an Earnings ESP of +0.59% and a Zacks Rank of 2 at present. The company is slated to release fourth-quarter 2025 results on Feb. 11.
Watts Water’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 10.9%.